Details for: ATAD5
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 6.21rCSI 5.33%PRS 90.19
-
CSI 4.54rCSI 13.14%PRS 75.61
-
CSI 4.51rCSI 3.74%PRS 87.45
-
CSI 4.31rCSI 3.35%PRS 95.29
-
CSI 3.43rCSI 2.71%PRS 75.98
-
CSI 3.39rCSI 5.4%PRS 77.14
-
CSI 3.21rCSI 2.38%PRS 80.05
-
CSI 3.02rCSI 4.61%PRS 82.36
-
CSI 2.93rCSI 2.31%PRS 89.04
-
CSI 2.71rCSI 5.43%PRS 77.23
-
CSI 2.65rCSI 4.27%PRS 76.35
-
CSI 2.65rCSI 3.89%PRS 78.96
-
CSI 2.56rCSI 2.95%PRS 77.7
-
CSI 2.38rCSI 2.15%PRS 83.87
-
CSI 2.29rCSI 1.86%PRS 87.29
-
CSI 2.27rCSI 4.61%PRS 65.5
-
CSI 2.26rCSI 1.95%PRS 88.45
-
CSI 2.23rCSI 4%PRS 79.42
-
CSI 2.2rCSI 4.13%PRS 75.1
-
CSI 2.15rCSI 2.99%PRS 83.51
-
CSI 2.11rCSI 6.24%PRS 85.86
-
CSI 2.11rCSI 5.59%PRS 88.71
-
CSI 2.07rCSI 7.8%PRS 68.56
-
CSI 2.06rCSI 2.97%PRS 89.45
-
CSI 2.02rCSI 2.11%PRS 82.87
-
CSI 2.02rCSI 2.41%PRS 69.39
-
CSI 2rCSI 3.5%PRS 80.25
-
CSI 1.96rCSI 2.51%PRS 81.52
-
CSI 1.92rCSI 3.38%PRS 80.86
-
CSI 1.78rCSI 3.98%PRS 70.22
-
CSI 1.76rCSI 2.18%PRS 83.59
-
CSI 1.76rCSI 2.26%PRS 76.05
-
CSI 1.76rCSI 2.19%PRS 67.2
-
CSI 1.61rCSI 3.65%PRS 84.75
-
CSI 1.6rCSI 2.83%PRS 68.8
-
CSI 1.6rCSI 2.06%PRS 70.46
-
CSI 1.58rCSI 1.98%PRS 91.82
-
CSI 1.54rCSI 2.64%PRS 89.46
-
CSI 1.52rCSI 2.08%PRS 76.93
-
CSI 1.46rCSI 4.9%PRS 70.07
-
CSI 1.42rCSI 6.22%PRS 90.78
-
CSI 1.4rCSI 7.21%PRS 95.57
-
CSI 1.38rCSI 2.21%PRS 70.68
-
CSI 1.28rCSI 2.82%PRS 72.52
-
CSI 1.21rCSI 1.87%PRS 84
-
CSI 1.21rCSI 3.79%PRS 72.93
-
CSI 1.13rCSI 3.21%PRS 88.17
-
CSI 1.12rCSI 1.87%PRS 69.24
-
CSI 1.06rCSI 7.78%PRS 74.29
-
CSI 1.02rCSI 4.47%PRS 73.97
-
CSI 0.97rCSI 2.36%PRS 67.1
-
CSI 0.97rCSI 3.78%PRS 96.18
-
CSI 0.89rCSI 2.78%PRS 70.78
-
CSI 0.8rCSI 4.56%PRS 88.88
-
CSI 0.74rCSI 5.99%PRS 80.66
-
CSI 0.71rCSI 3.81%PRS 89.14
-
CSI 0.67rCSI 4.38%PRS 95.75
-
CSI 0.65rCSI 2.46%PRS 69.64
-
CSI 0.61rCSI 2.2%PRS 67.26
-
CSI 0.38rCSI 9.01%PRS 67.14
-
CSI 0.35rCSI 2.03%PRS 69.78
-
CSI 0.32rCSI 7.82%PRS 67.57
-
CSI 0.2rCSI 6.03%PRS 92.33
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1996209376
Symbol: ATAD5_HUMAN
Name: Chromosome fragility-associated gene 1 protein
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11468690
Title: Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.
PubMed ID: 11468690
DOI: 10.1086/323043
PubMed ID: 15983387
Title: Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis.
PubMed ID: 15983387
PubMed ID: 17974005
Title: The full-ORF clone resource of the German cDNA consortium.
PubMed ID: 17974005
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 16625196
Title: DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.
PubMed ID: 16625196
DOI: 10.1038/nature04689
PubMed ID: 13678589
Title: Elg1 forms an alternative PCNA-interacting RFC complex required to maintain genome stability.
PubMed ID: 13678589
PubMed ID: 17525332
Title: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.
PubMed ID: 17525332
PubMed ID: 18220336
Title: Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.
PubMed ID: 18220336
DOI: 10.1021/pr0705441
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19755857
Title: DNA damage responses by human ELG1 in S phase are important to maintain genomic integrity.
PubMed ID: 19755857
DOI: 10.4161/cc.8.19.9752
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 20147293
Title: Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1.
PubMed ID: 20147293
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21555454
Title: The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.
PubMed ID: 21555454
DOI: 10.1128/mcb.01341-10
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 23937667
Title: Alternative replication factor C protein, Elg1, maintains chromosome stability by regulating PCNA levels on chromatin.
PubMed ID: 23937667
DOI: 10.1111/gtc.12087
PubMed ID: 23277426
Title: ATAD5 regulates the lifespan of DNA replication factories by modulating PCNA level on the chromatin.
PubMed ID: 23277426
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 28112733
Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
PubMed ID: 28112733
DOI: 10.1038/nsmb.3366
PubMed ID: 31844045
Title: ATAD5 promotes replication restart by regulating RAD51 and PCNA in response to replication stress.
PubMed ID: 31844045
PubMed ID: 26282398
Title: EPS8L2 is a new causal gene for childhood onset autosomal recessive progressive hearing loss.
PubMed ID: 26282398
Sequence Information:
- Length: 1844
- Mass: 207570
- Checksum: A09A3C76CFC77BD1
- Sequence:
MVGVLAMAAA AAPPPVKDCE IEPCKKRKKD DDTSTCKTIT KYLSPLGKTR DRVFAPPKPS NILDYFRKTS PTNEKTQLGK ECKIKSPESV PVDSNKDCTT PLEMFSNVEF KKKRKRVNLS HQLNNIKTEN EAPIEISSDD SKEDYSLNND FVESSTSVLR YKKQVEVLAE NIQDTKSQPN TMTSLQNSKK VNPKQGTTKN DFKKLRKRKC RDVVDLSESL PLAEELNLLK KDGKDTKQME NTTSHANSRD NVTEAAQLND SIITVSYEEF LKSHKENKVE EIPDSTMSIC VPSETVDEIV KSGYISESEN SEISQQVRFK TVTVLAQVHP IPPKKTGKIP RIFLKQKQFE MENSLSDPEN EQTVQKRKSN VVIQEEELEL AVLEAGSSEA VKPKCTLEER QQFMKAFRQP ASDALKNGVK KSSDKQKDLN EKCLYEVGRD DNSKKIMENS GIQMVSKNGN LQLHTDKGSF LKEKNKKLKK KNKKTLDTGA IPGKNREGNT QKKETTFFLK EKQYQNRMSL RQRKTEFFKS STLFNNESLV YEDIANDDLL KVSSLCNNNK LSRKTSIPVK DIKLTQSKAE SEASLLNVST PKSTRRSGRI SSTPTTETIR GIDSDDVQDN SQLKASTQKA ANLSEKHSLY TAELITVPFD SESPIRMKFT RISTPKKSKK KSNKRSEKSE ATDGGFTSQI RKASNTSKNI SKAKQLIEKA KALHISRSKV TEEIAIPLRR SSRHQTLPER KKLSETEDSV IIIDSSPTAL KHPEKNQKKL QCLNDVLGKK LNTSTKNVPG KMKVAPLFLV RKAQKAADPV PSFDESSQDT SEKSQDCDVQ CKAKRDFLMS GLPDLLKRQI AKKAAALDVY NAVSTSFQRV VHVQQKDDGC CLWHLKPPSC PLLTKFKELN TKVIDLSKCG IALGEFSTLN SKLKSGNSAA VFMRTRKEFT EEVRNLLLEE IRWSNPEFSL KKYFPLLLKK QIEHQVLSSE CHSKQELEAD VSHKETKRKL VEAENSKSKR KKPNEYSKNL EKTNRKSEEL SKRNNSSGIK LDSSKDSGTE DMLWTEKYQP QTASELIGNE LAIKKLHSWL KDWKRRAELE ERQNLKGKRD EKHEDFSGGI DFKGSSDDEE ESRLCNTVLI TGPTGVGKTA AVYACAQELG FKIFEVNASS QRSGRQILSQ LKEATQSHQV DKQGVNSQKP CFFNSYYIGK SPKKISSPKK VVTSPRKVPP PSPKSSGPKR ALPPKTLANY FKVSPKPKNN EEIGMLLENN KGIKNSFEQK QITQTKSTNA TNSNVKDVGA EEPSRKNATS LILFEEVDVI FDEDAGFLNA IKTFMATTKR PVILTTSDPT FSLMFDGCFE EIKFSTPSLL NVASYLQMIC LTENFRTDVK DFVTLLTANT CDIRKSILYL QFWIRSGGGV LEERPLTLYR GNSRNVQLVC SEHGLDNKIY PKNTKKKRVD LPKCDSGCAE TLFGLKNIFS PSEDLFSFLK HKITMKEEWH KFIQLLTEFQ MRNVDFLYSN LEFILPLPVD TIPETKNFCG PSVTVDASAA TKSMNCLARK HSEREQPLKK SQKKKQKKTL VILDDSDLFD TDLDFPDQSI SLSSVSSSSN AEESKTGDEE SKARDKGNNP ETKKSIPCPP KTTAGKKCSA LVSHCLNSLS EFMDNMSFLD ALLTDVREQN KYGRNDFSWT NGKVTSGLCD EFSLESNDGW TSQSSGELKA AAEALSFTKC SSAISKALET LNSCKKLGRD PTNDLTFYVS QKRNNVYFSQ SAANLDNAWK RISVIKSVFS SRSLLYVGNR QASIIEYLPT LRNICKTEKL KEQGKSKRRF LHYFEGIHLD IPKETVNTLA ADFP